| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 99283 |
Emergency department visit for the evaluation and management, moderate severity |
53,926 |
40,911 |
$9.11M |
| 99281 |
Emergency department visit for the evaluation and management, self-limited or minor |
32,584 |
25,297 |
$5.24M |
| 99282 |
Emergency department visit for the evaluation and management, low to moderate severity |
29,365 |
23,169 |
$5.16M |
| 99284 |
Emergency department visit for the evaluation and management, high severity |
26,360 |
19,007 |
$4.91M |
| G0378 |
Hospital observation service, per hour |
22,854 |
8,364 |
$4.53M |
| 74177 |
Computed tomography, abdomen and pelvis; with contrast material |
8,772 |
6,511 |
$2.93M |
| 99285 |
Emergency department visit for the evaluation and management, high severity with immediate threat to life |
17,126 |
11,194 |
$2.53M |
| 85025 |
Blood count; complete (CBC), automated, and automated differential WBC count |
116,585 |
74,908 |
$1.77M |
| 93005 |
Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report |
40,413 |
27,790 |
$1.77M |
| G0463 |
Hospital outpatient clinic visit for assessment and management of a patient |
27,571 |
17,638 |
$1.72M |
| 70450 |
Computed tomography, head or brain; without contrast material |
12,008 |
8,588 |
$1.49M |
| 87633 |
Infectious agent detection by nucleic acid, respiratory virus, 12-25 targets |
2,747 |
2,306 |
$1.28M |
| 96375 |
Therapeutic injection; each additional sequential IV push |
18,806 |
11,867 |
$1.17M |
| 71045 |
Radiologic examination, chest; single view |
35,743 |
24,728 |
$1.14M |
| 96374 |
Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance |
27,142 |
18,381 |
$1.13M |
| 93306 |
Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete |
1,764 |
1,442 |
$1.10M |
| 80053 |
Comprehensive metabolic panel |
89,187 |
61,019 |
$1.07M |
| 0241U |
Neonatal screening for hereditary disorders, genomic sequence analysis panel |
4,609 |
3,591 |
$1.03M |
| 0240U |
|
9,539 |
5,449 |
$981K |
| 76819 |
Fetal biophysical profile; without non-stress testing |
25,874 |
10,107 |
$937K |
| 71275 |
Computed tomographic angiography, chest, with contrast material |
2,767 |
1,968 |
$795K |
| 96365 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour |
8,120 |
4,975 |
$784K |
| 96361 |
Intravenous infusion, hydration; each additional hour |
11,658 |
8,421 |
$763K |
| 36415 |
Collection of venous blood by venipuncture |
148,928 |
93,937 |
$743K |
| Q9967 |
Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml |
14,471 |
10,347 |
$731K |
| G0480 |
Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed |
14,425 |
9,241 |
$681K |
| 93975 |
|
3,276 |
2,412 |
$664K |
| 59025 |
Fetal non-stress test |
4,227 |
2,016 |
$618K |
| 76816 |
Ultrasound, pregnant uterus, real time with image documentation, follow-up |
14,131 |
8,823 |
$605K |
| 84484 |
|
28,976 |
18,492 |
$549K |
| 72125 |
Computed tomography, cervical spine; without contrast material |
3,755 |
2,640 |
$530K |
| 11042 |
Debridement, subcutaneous tissue (includes epidermis, dermis, and subcutaneous tissue); first 20 sq cm |
2,593 |
1,102 |
$510K |
| 96360 |
Intravenous infusion, hydration; initial, 31 minutes to 1 hour |
8,001 |
5,446 |
$500K |
| 93976 |
|
2,604 |
1,441 |
$490K |
| 87502 |
Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets |
5,820 |
4,662 |
$473K |
| 81001 |
|
47,368 |
33,802 |
$413K |
| 87486 |
|
2,486 |
2,096 |
$406K |
| 76811 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed |
6,755 |
4,293 |
$397K |
| 74176 |
Computed tomography, abdomen and pelvis; without contrast material |
3,096 |
2,163 |
$383K |
| 83690 |
|
20,349 |
14,199 |
$380K |
| 94640 |
Pressurized or nonpressurized inhalation treatment for acute airway obstruction |
7,999 |
3,255 |
$373K |
| U0004 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc, making use of high throughput technologies as described by cms-2020-01-r |
5,717 |
4,186 |
$364K |
| 96413 |
Chemotherapy administration, intravenous infusion; up to 1 hour, single or initial substance |
2,362 |
938 |
$351K |
| 97110 |
Therapeutic procedure, each 15 minutes; therapeutic exercises to develop strength and endurance, flexibility and range of motion |
8,724 |
2,108 |
$347K |
| 99213 |
Office or other outpatient visit for the evaluation and management of an established patient, low complexity |
10,605 |
8,323 |
$346K |
| 99214 |
Office or other outpatient visit for the evaluation and management of an established patient, moderate complexity |
6,231 |
4,688 |
$343K |
| 87631 |
|
2,367 |
2,004 |
$329K |
| 83735 |
|
39,012 |
24,084 |
$311K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
3,633 |
2,067 |
$301K |
| 80050 |
General health panel |
5,948 |
4,802 |
$288K |
| 84703 |
|
10,673 |
7,424 |
$269K |
| 97140 |
Manual therapy techniques, each 15 minutes (e.g., mobilization/manipulation, manual lymphatic drainage) |
5,036 |
1,244 |
$265K |
| 90792 |
Psychiatric diagnostic evaluation with medical services |
2,418 |
1,681 |
$236K |
| 71260 |
Computed tomography, thorax, diagnostic; with contrast material |
1,518 |
1,188 |
$232K |
| 93971 |
|
1,810 |
1,533 |
$228K |
| 76805 |
Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation |
4,210 |
2,830 |
$222K |
| 96372 |
Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular |
8,648 |
5,843 |
$221K |
| C1713 |
Anchor/screw for opposing bone-to-bone or soft tissue-to-bone (implantable) |
628 |
195 |
$208K |
| 80048 |
Basic metabolic panel (calcium, ionized) |
31,051 |
18,967 |
$206K |
| 76817 |
Ultrasound, pregnant uterus, real time with image documentation, transvaginal |
4,757 |
2,619 |
$191K |
| 80061 |
Lipid panel |
15,154 |
11,547 |
$189K |
| 93970 |
|
978 |
772 |
$182K |
| 76821 |
|
5,384 |
2,426 |
$181K |
| 71046 |
Radiologic examination, chest; 2 views |
12,783 |
10,641 |
$180K |
| 76856 |
Ultrasound, pelvic (nonobstetric), real time with image documentation; complete |
3,262 |
2,684 |
$177K |
| 70486 |
|
1,141 |
949 |
$172K |
| 82550 |
|
22,775 |
15,650 |
$171K |
| 83036 |
Hemoglobin; glycosylated (A1C) |
10,805 |
8,222 |
$170K |
| 82306 |
Vitamin D; 25 hydroxy, includes fraction(s), if performed |
5,117 |
3,758 |
$168K |
| 77067 |
Screening mammography, bilateral, including computer-aided detection |
2,667 |
2,317 |
$167K |
| 76801 |
|
3,974 |
2,508 |
$166K |
| 76830 |
Ultrasound, transvaginal |
2,737 |
2,208 |
$164K |
| 78815 |
Positron emission tomography (PET) for limited area imaging |
282 |
248 |
$162K |
| 71250 |
|
1,653 |
1,404 |
$153K |
| 96366 |
Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour |
2,433 |
1,334 |
$150K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
4,581 |
3,483 |
$150K |
| 93458 |
|
47 |
41 |
$149K |
| 87086 |
Culture, bacterial; quantitative colony count, urine |
14,481 |
10,582 |
$145K |
| 81025 |
|
10,462 |
7,518 |
$138K |
| 84443 |
Thyroid stimulating hormone (TSH) |
9,144 |
6,860 |
$137K |
| 85730 |
|
19,343 |
13,680 |
$136K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
4,581 |
3,482 |
$133K |
| 76820 |
|
6,950 |
3,151 |
$129K |
| 96376 |
|
2,667 |
1,664 |
$127K |
| J1100 |
Injection, dexamethasone sodium phosphate, 1 mg |
8,563 |
4,010 |
$127K |
| 84439 |
|
6,356 |
4,454 |
$126K |
| 11045 |
|
58 |
25 |
$119K |
| 87798 |
Infectious agent detection by nucleic acid; not otherwise specified, amplified probe, each organism |
2,421 |
2,033 |
$116K |
| J2469 |
Injection, palonosetron hcl, 25 mcg |
911 |
389 |
$116K |
| 99204 |
Office or other outpatient visit for the evaluation and management of a new patient, moderate complexity |
1,637 |
1,394 |
$114K |
| 76700 |
Ultrasound, abdominal, real time with image documentation; complete |
2,170 |
1,809 |
$112K |
| 00170 |
Anesthesia for intraoral procedures, including biopsy |
275 |
240 |
$112K |
| 87581 |
|
2,486 |
2,096 |
$110K |
| 76815 |
Ultrasound, pregnant uterus, real time with image documentation, limited |
3,333 |
1,866 |
$104K |
| 76705 |
Ultrasound, abdominal, real time with image documentation; limited |
1,572 |
1,304 |
$102K |
| 87040 |
|
4,560 |
3,045 |
$101K |
| 73564 |
|
4,717 |
3,183 |
$101K |
| 41899 |
Unlisted procedure, dentoalveolar structures |
98 |
87 |
$100K |
| 93017 |
|
510 |
394 |
$100K |
| 99203 |
Office or other outpatient visit for the evaluation and management of a new patient, low complexity |
1,875 |
1,697 |
$100K |
| 43239 |
Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple |
342 |
279 |
$99K |
| 99222 |
Initial hospital care, per day, moderate complexity |
1,879 |
1,377 |
$93K |
| 84702 |
|
3,417 |
2,292 |
$88K |
| 83880 |
|
3,406 |
2,169 |
$88K |
| 78452 |
Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress |
334 |
243 |
$84K |
| J3490 |
Unclassified drugs |
12,772 |
5,501 |
$83K |
| 94664 |
|
3,497 |
1,391 |
$80K |
| 85027 |
|
12,677 |
7,423 |
$80K |
| 70551 |
Magnetic resonance imaging, brain; without contrast material |
598 |
458 |
$80K |
| 87070 |
|
5,069 |
4,202 |
$77K |
| 85610 |
|
23,057 |
15,663 |
$77K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
2,382 |
1,961 |
$77K |
| J1439 |
Injection, ferric carboxymaltose, 1 mg |
160 |
76 |
$73K |
| 76642 |
|
2,470 |
1,663 |
$73K |
| 97161 |
|
2,193 |
1,289 |
$72K |
| 97112 |
Therapeutic procedure, each 15 minutes; neuromuscular reeducation of movement, balance, coordination |
1,629 |
468 |
$69K |
| J2704 |
Injection, propofol, 10 mg |
11,017 |
4,588 |
$66K |
| 94762 |
|
996 |
324 |
$64K |
| 82553 |
|
6,701 |
4,553 |
$64K |
| J0131 |
Injection, acetaminophen, not otherwise specified,10 mg |
5,946 |
1,940 |
$64K |
| 73130 |
|
3,094 |
2,203 |
$63K |
| 82728 |
|
4,161 |
3,145 |
$63K |
| 87507 |
|
311 |
276 |
$62K |
| J1756 |
Injection, iron sucrose, 1 mg |
668 |
262 |
$62K |
| 82962 |
|
22,594 |
8,777 |
$62K |
| C1769 |
Guide wire |
1,004 |
475 |
$62K |
| 73030 |
|
3,322 |
2,408 |
$61K |
| 73610 |
|
2,877 |
2,092 |
$59K |
| 97530 |
Therapeutic activities, direct patient contact, each 15 minutes |
1,947 |
676 |
$55K |
| J1650 |
Injection, enoxaparin sodium, 10 mg |
2,326 |
663 |
$55K |
| 73630 |
|
2,881 |
2,192 |
$54K |
| 96367 |
|
932 |
536 |
$53K |
| 99233 |
Prolong inpt eval add15 m |
1,269 |
654 |
$53K |
| 84466 |
|
3,037 |
2,342 |
$51K |
| 83605 |
|
5,224 |
3,361 |
$50K |
| 85379 |
|
2,500 |
1,910 |
$50K |
| 86850 |
|
4,890 |
3,096 |
$49K |
| 77065 |
Tomosynthesis, mammo |
1,116 |
861 |
$48K |
| 99212 |
Office or other outpatient visit for the evaluation and management of an established patient, straightforward |
1,874 |
1,533 |
$48K |
| 87389 |
Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies |
1,670 |
1,272 |
$47K |
| 82607 |
|
2,361 |
1,683 |
$47K |
| 76770 |
|
1,019 |
878 |
$46K |
| 86901 |
|
6,134 |
4,024 |
$45K |
| A9552 |
Fluorodeoxyglucose f-18 fdg, diagnostic, per study dose, up to 45 millicuries |
327 |
287 |
$45K |
| C9803 |
Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
3,740 |
2,968 |
$45K |
| 97165 |
|
1,686 |
1,031 |
$45K |
| 83540 |
|
3,880 |
2,977 |
$43K |
| 99221 |
|
1,158 |
959 |
$43K |
| 88304 |
|
1,660 |
624 |
$42K |
| 70553 |
Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences |
202 |
169 |
$41K |
| 93880 |
|
263 |
221 |
$40K |
| 83655 |
|
1,725 |
1,423 |
$39K |
| 76536 |
|
949 |
854 |
$39K |
| J1885 |
Injection, ketorolac tromethamine, per 15 mg |
15,228 |
9,397 |
$39K |
| 86140 |
|
4,950 |
3,664 |
$38K |
| 99223 |
Prolong inpt eval add15 m |
544 |
435 |
$37K |
| 77066 |
Tomosynthesis, mammo |
652 |
497 |
$37K |
| 94760 |
|
3,358 |
1,314 |
$37K |
| 90715 |
|
1,708 |
1,428 |
$36K |
| 87880 |
Infectious agent antigen detection by immunoassay; Streptococcus, group A |
3,438 |
2,973 |
$36K |
| 73110 |
|
2,025 |
1,516 |
$36K |
| 77063 |
Screening digital breast tomosynthesis, bilateral |
2,602 |
2,269 |
$36K |
| 88307 |
|
1,173 |
717 |
$35K |
| A9500 |
Technetium tc-99m sestamibi, diagnostic, per study dose |
428 |
315 |
$35K |
| 86900 |
|
5,107 |
3,241 |
$35K |
| 99232 |
Subsequent hospital care, per day, moderate complexity |
1,155 |
637 |
$35K |
| 77336 |
|
603 |
121 |
$34K |
| J0696 |
Injection, ceftriaxone sodium, per 250 mg |
3,481 |
1,851 |
$32K |
| 87186 |
|
3,262 |
2,439 |
$31K |
| 87651 |
Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe |
773 |
559 |
$30K |
| 82746 |
|
1,426 |
983 |
$30K |
| 87077 |
|
3,642 |
2,716 |
$28K |
| 73140 |
|
1,090 |
884 |
$28K |
| U0002 |
2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc |
727 |
515 |
$27K |
| J2785 |
Injection, regadenoson, 0.1 mg |
242 |
163 |
$27K |
| 82570 |
|
3,885 |
2,764 |
$27K |
| J1453 |
Injection, fosaprepitant, 1 mg |
116 |
66 |
$27K |
| 82043 |
|
2,473 |
2,013 |
$27K |
| 36591 |
|
2,336 |
1,017 |
$26K |
| 97010 |
|
1,861 |
596 |
$26K |
| 72100 |
|
1,608 |
1,339 |
$25K |
| 83874 |
|
4,680 |
3,461 |
$25K |
| 88342 |
|
855 |
446 |
$25K |
| 87522 |
Neg quan hep c or qual rna |
439 |
349 |
$24K |
| 84100 |
|
5,118 |
2,898 |
$24K |
| 80307 |
Drug test(s), presumptive, any number of drug classes; immunoassay |
352 |
219 |
$24K |
| 88341 |
|
342 |
179 |
$23K |
| 80076 |
|
3,138 |
2,459 |
$23K |
| A9575 |
Injection, gadoterate meglumine, 0.1 ml |
1,003 |
830 |
$23K |
| J1644 |
Injection, heparin sodium, per 1000 units |
10,487 |
2,356 |
$23K |
| C1894 |
Introducer/sheath, other than guiding, other than intracardiac electrophysiological, non-laser |
596 |
355 |
$23K |
| 72148 |
Magnetic resonance imaging, lumbar spine; without contrast material |
387 |
350 |
$23K |
| 76813 |
|
563 |
262 |
$22K |
| J2791 |
Injection, rho(d) immune globulin (human), (rhophylac), intramuscular or intravenous, 100 iu |
173 |
144 |
$22K |
| 96415 |
|
103 |
58 |
$22K |
| 97116 |
|
996 |
302 |
$22K |
| 84112 |
|
274 |
154 |
$21K |
| J2270 |
Injection, morphine sulfate, up to 10 mg |
10,121 |
4,516 |
$21K |
| J2710 |
Injection, neostigmine methylsulfate, up to 0.5 mg |
2,440 |
869 |
$20K |
| 12001 |
|
343 |
294 |
$19K |
| 97597 |
|
477 |
253 |
$19K |
| 82150 |
|
2,758 |
1,797 |
$19K |
| 74018 |
|
1,530 |
1,239 |
$19K |
| 84436 |
|
2,667 |
1,862 |
$19K |
| 73721 |
Magnetic resonance imaging, any joint of lower extremity; without contrast material |
240 |
207 |
$18K |
| 85652 |
|
4,725 |
3,566 |
$18K |
| J3480 |
Injection, potassium chloride, per 2 meq |
1,869 |
846 |
$18K |
| J2920 |
Injection, methylprednisolone sodium succinate, up to 40 mg |
1,573 |
516 |
$18K |
| J3010 |
Injection, fentanyl citrate, 0.1 mg |
10,250 |
4,455 |
$18K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
317 |
251 |
$18K |
| 73502 |
|
1,395 |
1,158 |
$18K |
| 72110 |
|
1,169 |
1,013 |
$18K |
| 96417 |
|
90 |
48 |
$18K |
| J3475 |
Injection, magnesium sulfate, per 500 mg |
1,080 |
541 |
$17K |
| 97162 |
|
351 |
295 |
$17K |
| J0360 |
Injection, hydralazine hcl, up to 20 mg |
1,770 |
873 |
$17K |
| 86803 |
|
961 |
779 |
$17K |
| 99215 |
Prolong outpt/office vis |
173 |
150 |
$15K |
| 84479 |
|
1,801 |
1,202 |
$15K |
| 87210 |
|
2,220 |
1,632 |
$15K |
| 73080 |
|
871 |
691 |
$15K |
| J0690 |
Injection, cefazolin sodium, 500 mg |
2,808 |
793 |
$15K |
| 84550 |
|
1,998 |
1,316 |
$14K |
| G0279 |
Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) |
1,144 |
891 |
$14K |
| J2930 |
Injection, methylprednisolone sodium succinate, up to 125 mg |
2,572 |
1,490 |
$14K |
| 87205 |
|
2,005 |
1,495 |
$14K |
| 10060 |
|
395 |
297 |
$13K |
| 00731 |
|
278 |
233 |
$13K |
| 73590 |
|
724 |
577 |
$13K |
| 80074 |
|
362 |
281 |
$13K |
| C1751 |
Catheter, infusion, inserted peripherally, centrally or midline (other than hemodialysis) |
522 |
368 |
$13K |
| 84460 |
|
1,377 |
847 |
$13K |
| 36430 |
|
210 |
113 |
$13K |
| J1170 |
Injection, hydromorphone, up to 4 mg |
5,248 |
1,567 |
$13K |
| 70544 |
|
49 |
41 |
$13K |
| 86038 |
|
772 |
644 |
$12K |
| 93010 |
Electrocardiogram, routine ECG with at least 12 leads; interpretation and report only |
13,382 |
9,155 |
$12K |
| 84450 |
|
1,235 |
724 |
$12K |
| 84156 |
|
1,706 |
992 |
$12K |
| J2405 |
Injection, ondansetron hydrochloride, per 1 mg |
22,349 |
11,719 |
$12K |
| 80069 |
|
1,868 |
835 |
$11K |
| 76870 |
|
220 |
190 |
$11K |
| G0297 |
Low dose ct scan (ldct) for lung cancer screening |
91 |
85 |
$10K |
| J3370 |
Injection, vancomycin hcl, 500 mg |
508 |
199 |
$10K |
| 82803 |
|
748 |
416 |
$10K |
| 82248 |
|
1,064 |
780 |
$10K |
| 86618 |
|
344 |
294 |
$10K |
| 82565 |
|
1,412 |
889 |
$10K |
| 72040 |
|
684 |
581 |
$10K |
| J2310 |
Injection, naloxone hydrochloride, per 1 mg |
468 |
248 |
$10K |
| 73090 |
|
582 |
462 |
$10K |
| P9016 |
Red blood cells, leukocytes reduced, each unit |
102 |
61 |
$10K |
| 74022 |
|
648 |
518 |
$9K |
| 80143 |
|
645 |
446 |
$9K |
| 84520 |
|
1,374 |
857 |
$9K |
| 94799 |
|
1,129 |
217 |
$9K |
| 96523 |
|
604 |
315 |
$9K |
| C1887 |
Catheter, guiding (may include infusion/perfusion capability) |
290 |
118 |
$9K |
| 86780 |
|
399 |
346 |
$9K |
| 86617 |
|
204 |
166 |
$9K |
| 80179 |
|
586 |
414 |
$9K |
| 84403 |
|
226 |
198 |
$9K |
| 97113 |
|
105 |
33 |
$9K |
| 82247 |
|
747 |
557 |
$8K |
| 83970 |
|
388 |
264 |
$8K |
| 72050 |
|
479 |
416 |
$8K |
| 94060 |
|
49 |
41 |
$8K |
| 76827 |
|
222 |
104 |
$8K |
| 29125 |
|
114 |
108 |
$8K |
| J3411 |
Injection, thiamine hcl, 100 mg |
966 |
341 |
$7K |
| 87147 |
|
987 |
755 |
$7K |
| 90471 |
Immunization administration (includes percutaneous, intradermal, subcutaneous, or intramuscular injections), 1 vaccine |
1,181 |
305 |
$7K |
| 87340 |
|
717 |
586 |
$7K |
| 71101 |
|
473 |
315 |
$7K |
| C1725 |
Catheter, transluminal angioplasty, non-laser (may include guidance, infusion/perfusion capability) |
15 |
13 |
$7K |
| J2543 |
Injection, piperacillin sodium/tazobactam sodium, 1 gram/0.125 grams (1.125 grams) |
79 |
26 |
$7K |
| 76942 |
|
58 |
39 |
$7K |
| 70491 |
|
169 |
148 |
$7K |
| C1760 |
Closure device, vascular (implantable/insertable) |
43 |
35 |
$6K |
| 72072 |
|
588 |
511 |
$6K |
| 86592 |
|
653 |
534 |
$6K |
| 73560 |
|
344 |
223 |
$6K |
| 86923 |
|
106 |
69 |
$6K |
| 90686 |
|
411 |
324 |
$6K |
| 01961 |
|
70 |
69 |
$6K |
| J0330 |
Injection, succinylcholine chloride, up to 20 mg |
872 |
300 |
$6K |
| 29505 |
|
56 |
56 |
$6K |
| 12011 |
|
134 |
116 |
$5K |
| 83615 |
|
593 |
476 |
$5K |
| G0103 |
Prostate cancer screening; prostate specific antigen test (psa) |
347 |
281 |
$5K |
| 82009 |
|
1,027 |
654 |
$5K |
| 83883 |
|
181 |
81 |
$5K |
| J2250 |
Injection, midazolam hydrochloride, per 1 mg |
8,455 |
3,622 |
$5K |
| 97802 |
|
76 |
76 |
$4K |
| J1953 |
Injection, levetiracetam, 10 mg |
267 |
83 |
$4K |
| 92507 |
Treatment of speech, language, voice, communication, and/or auditory processing disorder |
49 |
18 |
$4K |
| 93925 |
|
31 |
25 |
$4K |
| 84153 |
|
223 |
206 |
$4K |
| C9113 |
Injection, pantoprazole sodium, per vial |
1,870 |
538 |
$4K |
| 73221 |
|
84 |
69 |
$4K |
| 86665 |
|
86 |
67 |
$4K |
| J1940 |
Injection, furosemide, up to 20 mg |
316 |
155 |
$4K |
| J0780 |
Injection, prochlorperazine, up to 10 mg |
366 |
225 |
$4K |
| 84480 |
|
317 |
259 |
$4K |
| 80164 |
|
421 |
312 |
$4K |
| 99202 |
Office or other outpatient visit for the evaluation and management of a new patient, straightforward |
74 |
68 |
$3K |
| 99205 |
Prolong outpt/office vis |
28 |
27 |
$3K |
| 99442 |
|
58 |
52 |
$3K |
| 83516 |
|
119 |
101 |
$3K |
| J2060 |
Injection, lorazepam, 2 mg |
2,631 |
1,400 |
$3K |
| 73060 |
|
150 |
121 |
$3K |
| 86308 |
|
311 |
248 |
$3K |
| 36600 |
|
292 |
142 |
$3K |
| 0002A |
|
134 |
95 |
$3K |
| G0416 |
Surgical pathology, gross and microscopic examinations, for prostate needle biopsy, any method |
15 |
15 |
$3K |
| 96411 |
|
26 |
12 |
$3K |
| 85018 |
|
910 |
647 |
$2K |
| J2765 |
Injection, metoclopramide hcl, up to 10 mg |
2,474 |
1,448 |
$2K |
| 87493 |
|
169 |
131 |
$2K |
| 82977 |
|
205 |
166 |
$2K |
| 82533 |
|
77 |
64 |
$2K |
| A9577 |
Injection, gadobenate dimeglumine (multihance), per ml |
277 |
222 |
$2K |
| 82784 |
|
98 |
79 |
$2K |
| 86431 |
|
481 |
403 |
$2K |
| J2550 |
Injection, promethazine hcl, up to 50 mg |
1,646 |
816 |
$2K |
| 0001A |
|
167 |
104 |
$2K |
| 85014 |
|
840 |
515 |
$2K |
| 99231 |
Subsequent hospital care, per day, straightforward or low complexity |
348 |
144 |
$2K |
| J1956 |
Injection, levofloxacin, 250 mg |
233 |
98 |
$2K |
| J7512 |
Prednisone, immediate release or delayed release, oral, 1 mg |
2,615 |
1,762 |
$2K |
| 73552 |
|
167 |
131 |
$2K |
| 00840 |
|
28 |
13 |
$2K |
| J3301 |
Injection, triamcinolone acetonide, not otherwise specified, 10 mg |
34 |
27 |
$2K |
| 82272 |
|
362 |
304 |
$2K |
| 74183 |
|
35 |
26 |
$1K |
| 81003 |
|
236 |
151 |
$1K |
| J1630 |
Injection, haloperidol, up to 5 mg |
116 |
97 |
$1K |
| 86664 |
|
64 |
53 |
$1K |
| J0456 |
Injection, azithromycin, 500 mg |
120 |
58 |
$1K |
| 76818 |
|
74 |
50 |
$1K |
| 29515 |
|
13 |
12 |
$1K |
| 99219 |
|
14 |
14 |
$1K |
| 85007 |
|
410 |
272 |
$1K |
| 96368 |
|
15 |
12 |
$1K |
| 70498 |
|
13 |
12 |
$1K |
| G2023 |
Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source |
169 |
141 |
$1K |
| 97535 |
Self-care/home management training, each 15 minutes |
89 |
36 |
$1K |
| 72141 |
|
49 |
41 |
$1K |
| 12002 |
|
88 |
79 |
$1K |
| 84146 |
|
33 |
27 |
$1K |
| 77427 |
|
85 |
26 |
$935.84 |
| 83010 |
|
45 |
39 |
$916.43 |
| 85045 |
|
383 |
279 |
$914.27 |
| 88173 |
|
70 |
30 |
$887.28 |
| 99441 |
|
31 |
30 |
$860.52 |
| J0171 |
Injection, adrenalin, epinephrine, 0.1 mg |
65 |
41 |
$846.62 |
| 94729 |
|
15 |
12 |
$777.75 |
| 0012A |
|
135 |
61 |
$742.30 |
| 84145 |
|
56 |
25 |
$725.70 |
| 86376 |
|
91 |
68 |
$725.70 |
| 77080 |
|
32 |
26 |
$724.30 |
| 80177 |
|
81 |
50 |
$721.66 |
| 0011A |
|
120 |
61 |
$696.65 |
| 86003 |
|
32 |
27 |
$600.48 |
| J0500 |
Injection, dicyclomine hcl, up to 20 mg |
50 |
42 |
$596.53 |
| 70360 |
|
31 |
28 |
$583.62 |
| 99356 |
|
40 |
28 |
$581.89 |
| C1753 |
Catheter, intravascular ultrasound |
170 |
45 |
$524.44 |
| 84165 |
|
117 |
25 |
$464.35 |
| 73562 |
|
353 |
239 |
$458.67 |
| 84155 |
|
131 |
38 |
$396.35 |
| J7510 |
Prednisolone oral, per 5 mg |
513 |
389 |
$386.16 |
| 73522 |
|
28 |
25 |
$375.61 |
| 82270 |
|
501 |
353 |
$360.05 |
| 99358 |
Prolong nursin fac eval 15m |
12 |
12 |
$356.37 |
| 69436 |
Tympanostomy (requiring insertion of ventilating tube), general anesthesia |
33 |
26 |
$356.30 |
| 73100 |
|
37 |
25 |
$348.38 |
| 82140 |
|
15 |
12 |
$348.13 |
| 19083 |
|
16 |
12 |
$293.44 |
| 76882 |
|
60 |
51 |
$246.66 |
| 80178 |
|
16 |
15 |
$234.63 |
| 88302 |
|
124 |
28 |
$176.66 |
| J7042 |
5% dextrose/normal saline (500 ml = 1 unit) |
18 |
13 |
$161.78 |
| 84132 |
|
38 |
25 |
$149.94 |
| J2001 |
Injection, lidocaine hcl for intravenous infusion, 10 mg |
50 |
40 |
$140.11 |
| 85347 |
|
16 |
14 |
$117.67 |
| 86225 |
|
14 |
12 |
$115.82 |
| 82785 |
|
46 |
40 |
$100.46 |
| 83001 |
|
12 |
12 |
$94.50 |
| 86762 |
|
19 |
13 |
$82.56 |
| 90714 |
|
18 |
13 |
$49.78 |
| 72170 |
|
16 |
12 |
$36.29 |
| G0008 |
Administration of influenza virus vaccine |
97 |
80 |
$29.46 |
| 93016 |
|
47 |
44 |
$25.02 |
| 89051 |
|
14 |
12 |
$19.59 |
| 86317 |
|
15 |
14 |
$17.66 |
| G1004 |
Clinical decision support mechanism national decision support company, as defined by the medicare appropriate use criteria program |
17,898 |
8,915 |
$10.45 |
| 88108 |
|
22 |
16 |
$9.49 |
| 88311 |
|
23 |
15 |
$5.26 |
| 91301 |
|
48 |
48 |
$0.43 |
| 91300 |
|
133 |
123 |
$0.34 |
| G8978 |
Mobility: walking & moving around functional limitation, current status, at therapy episode outset and at reporting intervals |
295 |
155 |
$0.02 |
| G8979 |
Mobility: walking & moving around functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
348 |
194 |
$0.02 |
| G8988 |
Self care functional limitation, projected goal status, at therapy episode outset, at reporting intervals, and at discharge or to end reporting |
47 |
27 |
$0.00 |
| G8987 |
Self care functional limitation, current status, at therapy episode outset and at reporting intervals |
47 |
27 |
$0.00 |
| 73660 |
|
17 |
15 |
$0.00 |
| 86160 |
|
27 |
24 |
$0.00 |